IA
EW icon

Inspire Advisors’s Edwards Lifesciences EW Stock Holding History

Inspire Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
12,654
+325
+3% +$27.2K 0.08% 206
2026
Q1 		$987K Buy
+12,329
New +$1.02M 0.08% 195
2024
Q1 		– Sell
-6,763
Closed -$516K – 391
2023
Q4 		$516K Sell
6,763
-1,100
-14% -$76.5K 0.08% 170
2023
Q3 		$545K Buy
+7,863
New +$632K 0.1% 124
2022
Q2 		– Sell
-4,513
Closed -$531K – 134
2022
Q1 		$531K Buy
4,513
+1,823
+68% +$205K 0.15% 24
2021
Q4 		$349K Buy
+2,690
New +$314K 0.1% 48

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Inspire Advisors's EW Position: Q2 2026 in Review

Inspire Advisors increased its Edwards Lifesciences (EW) stake by 2.6% in Q2 2026, buying an estimated $27.2K and bringing the position to 12,654 shares worth $1.14M. The position accounts for 0.08% of the portfolio, ranked #206.

Inspire Advisors first reported a position in EW in Q4 2021 and has held it in 6 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Inspire Advisors held 12,654 shares of Edwards Lifesciences worth $1.14M as of Q2 2026.
  • Inspire Advisors bought 325 Edwards Lifesciences shares in Q2 2026, an estimated $27.2K.
  • Edwards Lifesciences made up 0.08% of Inspire Advisors's portfolio in Q2 2026, its #206 holding.
  • Inspire Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 6 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.